These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 11800024

  • 21. Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
    Belani CP, Einzig A, Bonomi P, Dobbs T, Capozzoli MJ, Earhart R, Cohen LJ, Luketich JD.
    Ann Oncol; 2000 Jun; 11(6):673-8. PubMed ID: 10942054
    [Abstract] [Full Text] [Related]

  • 22. Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study.
    Pectasides D, Visvikis A, Kouloubinis A, Glotsos J, Bountouroglou N, Karvounis N, Ziras N, Athanassiou A.
    Eur J Cancer; 2002 Jun; 38(9):1194-200. PubMed ID: 12044505
    [Abstract] [Full Text] [Related]

  • 23. A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
    Kosmas C, Tsavaris NB, Makatsoris T, Onyenadum A, Vadiaka M, Stavroyianni N, Sepsas E, Dimitropoulos D, Rokana S, Kalofonos HP.
    Int J Cancer; 2002 Mar 01; 98(1):141-7. PubMed ID: 11857398
    [Abstract] [Full Text] [Related]

  • 24. Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.
    Socinski MA, Sandler AB, Miller LL, Locker PK, Hanover CK, Elfring GL, Israel VK, Pirotta N, Natale RB.
    J Clin Oncol; 2001 Feb 15; 19(4):1078-87. PubMed ID: 11181672
    [Abstract] [Full Text] [Related]

  • 25. Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
    Millward MJ, Zalcberg J, Bishop JF, Webster LK, Zimet A, Rischin D, Toner GC, Laird J, Cosolo W, Urch M, Bruno R, Loret C, James R, Blanc C.
    J Clin Oncol; 1997 Feb 15; 15(2):750-8. PubMed ID: 9053501
    [Abstract] [Full Text] [Related]

  • 26. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
    Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF.
    J Clin Oncol; 1995 Aug 15; 13(8):1860-70. PubMed ID: 7543559
    [Abstract] [Full Text] [Related]

  • 27. Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.
    Patnaik A, Warner E, Michael M, Egorin MJ, Moore MJ, Siu LL, Fracasso PM, Rivkin S, Kerr I, Litchman M, Oza AM.
    J Clin Oncol; 2000 Nov 01; 18(21):3677-89. PubMed ID: 11054441
    [Abstract] [Full Text] [Related]

  • 28. Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer.
    Belani CP, Kearns CM, Zuhowski EG, Erkmen K, Hiponia D, Zacharski D, Engstrom C, Ramanathan RK, Capozzoli MJ, Aisner J, Egorin MJ.
    J Clin Oncol; 1999 Feb 01; 17(2):676-84. PubMed ID: 10080614
    [Abstract] [Full Text] [Related]

  • 29. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer.
    Giaccone G, Huizing M, Postmus PE, ten Bokkel Huinink WW, Koolen M, van Zandwijk N, Vermorken JB, Beijnen JH, Dalesio O, Pinedo HM.
    Semin Oncol; 1995 Aug 01; 22(4 Suppl 9):78-82. PubMed ID: 7544030
    [Abstract] [Full Text] [Related]

  • 30. A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Horinouchi H, Yamamoto N, Nokihara H, Horai T, Nishio M, Ohyanagi F, Horiike A, Nakagawa K, Terashima M, Okabe T, Kaneda H, McKee MD, Carlson DM, Xiong H, Tamura T.
    Cancer Chemother Pharmacol; 2014 Jul 01; 74(1):37-43. PubMed ID: 24807459
    [Abstract] [Full Text] [Related]

  • 31. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP.
    Oncology (Williston Park); 1997 Aug 01; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [Abstract] [Full Text] [Related]

  • 32. Phase I and pharmacologic study of docetaxel and irinotecan in advanced non-small-cell lung cancer.
    Masuda N, Negoro S, Kudoh S, Sugiura T, Nakagawa K, Saka H, Takada M, Niitani H, Fukuoka M.
    J Clin Oncol; 2000 Aug 01; 18(16):2996-3003. PubMed ID: 10944133
    [Abstract] [Full Text] [Related]

  • 33. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
    Li JL, Zhang XR, Liu JW, Chen ZY, Lin YC, Wang YD, Chen Q, Nan KJ, Song SP, Han FC, Zhu YZ, Li LY, Zheng YH, Chu DT.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr 01; 28(4):309-12. PubMed ID: 16875636
    [Abstract] [Full Text] [Related]

  • 34. Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study.
    Belani CP, Aisner J, Hiponia D, Ramanathan R.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 12):19-21. PubMed ID: 8941406
    [Abstract] [Full Text] [Related]

  • 35. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
    Glorieux P, Ortmanns P, Marien S, Degives R, Degraeve D, Potvin M, Grauwels D, Schallier D.
    Anticancer Res; 2001 Oct 01; 21(2B):1487-94. PubMed ID: 11396237
    [Abstract] [Full Text] [Related]

  • 36. [Phase I study of docetaxel combined with carboplatin in patients with non-small cell lung cancer].
    Zhu LM, Li QY, Yu XM, Ma SL.
    Zhonghua Zhong Liu Za Zhi; 2006 Dec 01; 28(12):946-8. PubMed ID: 17533750
    [Abstract] [Full Text] [Related]

  • 37. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [Abstract] [Full Text] [Related]

  • 38. A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer.
    Sato K, Tsuchiya S, Minato K, Takei Y, Watanabe S, Saitoh R, Mori M.
    Lung Cancer; 2001 Jul 01; 33(1):69-73. PubMed ID: 11429197
    [Abstract] [Full Text] [Related]

  • 39. Dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.
    Morère JF, Piperno-Neumann S, Coulon MA, Vaylet F, L'Her P, Brunet A, Quinaux E, Breau JL.
    Anticancer Drugs; 2000 Aug 01; 11(7):541-8. PubMed ID: 11036956
    [Abstract] [Full Text] [Related]

  • 40. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
    Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA.
    Clin Cancer Res; 1997 Jul 01; 3(7):1117-23. PubMed ID: 9815791
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.